Examkin

Question

Difficulty: MediumPharmacologic Interventions

A 58-year-old man with a history of stage 5 chronic kidney disease is brought to the emergency department due to profound generalized weakness. He reports missing his last two scheduled hemodialysis sessions due to transportation issues. His blood pressure is 110/70 mmHg, and his pulse is 42/min. Physical examination shows flaccid muscle weakness in all four extremities. An electrocardiogram (ECG) reveals a heart rate of 42/min, absent P waves, a markedly widened QRS complex, and tall, peaked T waves. Point-of-care testing shows a serum potassium level of 8.6 mEq/L. Arrange the following pharmacologic interventions in the correct chronological sequence for the acute management of this patient, ordered from the most immediate priority to the subsequent steps.

  1. 1Intravenous calcium gluconate
  2. 2Intravenous regular insulin and 50% dextrose
  3. 3Oral sodium zirconium cyclosilicate

Answer

The correct sequence is: Intravenous calcium gluconate, followed by Intravenous regular insulin and 50% dextrose, followed by Oral sodium zirconium cyclosilicate.
The correct chronological sequence aligns with the pathophysiologic priorities of managing hyperkalemia accompanied by cardiac toxicity. Intravenous calcium directly antagonizes the membrane actions of hyperkalemia and must be given first to prevent imminent cardiac arrest. Once the myocardium is stabilized, insulin (co-administered with dextrose to prevent hypoglycemia) is utilized to drive potassium intracellularly, providing a rapid but temporary reduction in serum potassium levels. Finally, oral potassium binders such as sodium zirconium cyclosilicate are administered to excrete potassium from the body; their delayed onset of action relegates them to the final pharmacologic step in acute sequencing.

Step-by-Step Solution

1
Identify the life-threatening electrolyte derangement.
The patient has severe hyperkalemia (8.6 mEq/L) with critical ECG changes indicating impending cardiac arrest.
ECG changes such as absent P waves and a widened QRS complex require immediate intervention to prevent fatal arrhythmias.
2
Administer membrane-stabilizing therapy.
Intravenous calcium gluconate is given as the first priority.
Calcium directly antagonizes the effects of hyperkalemia on the myocardial cell membrane, acting within minutes to stabilize the heart.
3
Administer potassium-shifting agents.
Intravenous regular insulin (with dextrose to prevent hypoglycemia) is given.
Once the heart is stabilized, insulin is used to rapidly drive extracellular potassium into the cells, lowering serum levels.
4
Administer total body potassium elimination therapies.
Oral sodium zirconium cyclosilicate is given.
To permanently remove potassium from the body, gastrointestinal binders are used, though their onset is delayed (hours).

Key Concept

The sequential pharmacologic management of severe hyperkalemia with ECG changes prioritizes immediate cardiac membrane stabilization, followed by intracellular potassium shifting, and concludes with total body potassium elimination.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic